{
    "items": "50",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "SP Funds Dow Jones Global Sukuk ETF (NYSE: SPSK) - Dividends",
            "url": "https://www.intelligentinvestor.com.au/shares/nyse-spsk/sp-funds-dow-jones-global-sukuk-etf/dividends",
            "time_published": "20260228T055313",
            "authors": [],
            "summary": "This article provides a detailed list of past and upcoming dividend distributions for the SP Funds Dow Jones Global Sukuk ETF (NYSE: SPSK). It includes information such as distribution type, dividend franking percentage, ex-dividend date, payment date, current price, and 7-day average price for each dividend. The current trading price for SPSK is $18.345.",
            "banner_image": null,
            "source": "intelligentinvestor.com.au",
            "category_within_source": "General",
            "source_domain": "intelligentinvestor.com.au",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.948087"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.814531"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.703402"
                }
            ],
            "overall_sentiment_score": 0.111348,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPSK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.111317",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Schwab International Small-Cap Equity ETF Review and Aggregate Rating (SCHC)",
            "url": "https://www.marketbeat.com/stocks/NYSEARCA/SCHC/ratings/",
            "time_published": "20260228T055133",
            "authors": [
                "MarketBeat.com Staff"
            ],
            "summary": "This article provides a review and aggregate rating for the Schwab International Small-Cap Equity ETF (SCHC). Based on analyst ratings for its holdings, SCHC currently has an aggregate \"Buy\" rating with an average consensus price target of $51.54. The ratings are derived from Wall Street analysts' assessments of the ETF's underlying companies, with Equinox Gold being a significant holding contributing to the overall rating.",
            "banner_image": "https://www.marketbeat.com/logos/thumbnail/schwab-international-small-cap-equity-etf-logo.jpg?v=20210824092515",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.932845"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.735065"
                }
            ],
            "overall_sentiment_score": 0.514393,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SCHC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.520021",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Honeywell Portfolio Shake Up And Catalyst Deal Repricing Test Valuation",
            "url": "https://simplywall.st/stocks/us/capital-goods/nasdaq-hon/honeywell-international/news/honeywell-portfolio-shake-up-and-catalyst-deal-repricing-tes",
            "time_published": "20260228T053821",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Honeywell International is undergoing a significant portfolio reshaping, including planned asset sales, a spinoff of its aerospace and automation businesses, and an amended acquisition deal for Johnson Matthey's Catalyst Technologies. These strategic moves are expected to alter Honeywell's revenue mix and competitive position, with institutional investors already initiating new positions based on the anticipated impact. The company's shares are currently trading below analyst targets but above Simply Wall St's fair value estimate, indicating a rich valuation despite strong recent momentum.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.918749"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.726544"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.645020"
                }
            ],
            "overall_sentiment_score": 0.113194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HON",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.121123",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pool Corp (POOL) Margin Drift Challenges Bullish Earnings Narrative After FY 2025 Results",
            "url": "https://simplywall.st/stocks/us/retail/nasdaq-pool/pool/news/pool-corp-pool-margin-drift-challenges-bullish-earnings-narr",
            "time_published": "20260228T053759",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Pool Corp (POOL) closed FY 2025 with Q4 revenue of US$982.2 million and EPS of US$0.86, showing annual revenue of US$5.3 billion and EPS of US$10.89. Despite solid earnings, the company experienced a drift in net profit margins from 8.1% to 7.6% over the trailing twelve months, which challenges the bullish narrative, especially given a five-year earnings decline. Analysts forecast modest growth, with the large existing pool infrastructure and recurring maintenance providing some support against margin compression and slower growth compared to broader market averages.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/1txW1Rnk3fUjh2FW939y6e/a1bb305c92d46eae2c7f925893392fdd/avatar-v2.png?w=64&h=64&q=90&fit=fill&f=top",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "1.000000"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.806981"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.702751"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.646598"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.636819"
                }
            ],
            "overall_sentiment_score": -0.282654,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "POOL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.262861",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Pfizer\u2019s New mCRC Standard Of Care And What It Means For Valuation",
            "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizers-new-mcrc-standard-of-care-and-what-it-means-for-valu",
            "time_published": "20260228T053756",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Pfizer received full FDA approval for BRAFTOVI in combination with cetuximab and fluorouracil-based chemotherapy for BRAF V600E mutant metastatic colorectal cancer, establishing it as a new first-line standard of care. This approval expands Pfizer's oncology portfolio and is a clinically relevant asset for investors. The article notes Pfizer's stock currently trades below analyst targets but is considered undervalued by Simply Wall St's valuation model, while also flagging a potential risk regarding dividend coverage.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.942114"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.817225"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.730533"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.646283"
                }
            ],
            "overall_sentiment_score": 0.148408,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.405221",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.565315",
                    "ticker_sentiment_score": "-0.051352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.550505",
                    "ticker_sentiment_score": "-0.089436",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Booking Holdings Split And OpenTable Media Shift Growth Story",
            "url": "https://simplywall.st/stocks/us/consumer-services/nasdaq-bkng/booking-holdings/news/booking-holdings-split-and-opentable-media-shift-growth-stor",
            "time_published": "20260228T053747",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Booking Holdings announced a 25-for-1 stock split to increase accessibility for investors and introduced a new media solution via OpenTable to generate new ad revenue. These strategic moves aim to diversify Booking's revenue streams, attract a broader retail investor base, and leverage its existing restaurant network for advertising opportunities, expanding beyond its core booking commissions. Investors are advised to monitor how these changes impact trading activity, OpenTable Media adoption, and the company's financial performance.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.904996"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.947324"
                }
            ],
            "overall_sentiment_score": 0.409297,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BKNG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.420010",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Wynn Resorts (WYNN) Posts Steady Q4 Results as UAE Project Advances",
            "url": "https://finviz.com/news/325923/wynn-resorts-wynn-posts-steady-q4-results-as-uae-project-advances",
            "time_published": "20260228T053427",
            "authors": [
                "Sheryar Siddiq"
            ],
            "summary": "Wynn Resorts (NASDAQ: WYNN) reported steady fourth-quarter 2025 results, with an adjusted property EBITDAR of $569 million, despite missing earnings estimates. The company's Wynn Las Vegas and Macau operations showed strong performance, and construction on the Wynn Al Marjan Island in the UAE is progressing, with an expected opening in Q1 2027. This project is a key strategic focus for the luxury hotel and casino operator.",
            "banner_image": null,
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.927145"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.707166"
                }
            ],
            "overall_sentiment_score": 0.129657,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WYNN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.304700",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CZR",
                    "relevance_score": "0.604347",
                    "ticker_sentiment_score": "0.037680",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MGM",
                    "relevance_score": "0.588489",
                    "ticker_sentiment_score": "0.017951",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "ConocoPhillips Permian Sale Review Highlights Portfolio High Grading And Cash Goals",
            "url": "https://simplywall.st/stocks/us/energy/nyse-cop/conocophillips/news/conocophillips-permian-sale-review-highlights-portfolio-high",
            "time_published": "20260228T052957",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "ConocoPhillips is considering selling some Permian Basin assets for an estimated US$2 billion to streamline its portfolio and meet a US$5 billion divestiture goal by 2026. This move aligns with a strategy of high-grading assets, refocusing capital on higher-priority projects like Willow and LNG developments, especially after recent earnings missed expectations. Investors will be watching how this sale impacts future spending, capital allocation plans, and the company's long-term growth narrative in US shale versus larger, longer-lived projects.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.910532"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.834789"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.919269"
                }
            ],
            "overall_sentiment_score": 0.17335,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COP",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.255741",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.647690",
                    "ticker_sentiment_score": "0.105669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.618696",
                    "ticker_sentiment_score": "0.145900",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bank Of New York Mellon Capital Move Tests Valuation And Dividend Appeal",
            "url": "https://simplywall.st/stocks/us/diversified-financials/nyse-bk/bank-of-new-york-mellon/news/bank-of-new-york-mellon-capital-move-tests-valuation-and-div",
            "time_published": "20260228T052948",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Bank of New York Mellon Corporation (NYSE:BK) recently completed a $500 million preferred stock offering, with potential plans to redeem outstanding Series F and possibly Series H Preferred Stock. This move occurs while the company's shares have seen substantial appreciation, returning 36.4% over the past year and 151.5% over 3 years. Investors are now watching how this capital reshuffle will affect BNY's funding mix, cost of capital, and its impact on common share valuation and dividend sustainability.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "finance",
                    "relevance_score": "0.943545"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.837968"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.743922"
                }
            ],
            "overall_sentiment_score": 0.046232,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.031822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLK",
                    "relevance_score": "0.638315",
                    "ticker_sentiment_score": "0.041779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.621613",
                    "ticker_sentiment_score": "0.022610",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Procter And Gamble\u2019s USA Gymnastics Return And What It Means For Investors",
            "url": "https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/procter-and-gambles-usa-gymnastics-return-and-what-it-means",
            "time_published": "20260228T052757",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Procter & Gamble (NYSE:PG) has re-signed as a top-level sponsor for USA Gymnastics for the 2028 Los Angeles Olympics, marking the first partner to return since recent scandals. This sponsorship aims to enhance P&G's brand presence and consumer engagement around the home Olympics, reinforcing long-term brand strength and customer loyalty. For investors, while it represents a move towards brand building rather than immediate sales, it also indicates a perceived rehabilitation of USA Gymnastics and could support P&G's earnings growth, though potential reputational risks and marketing costs should be considered.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.812949"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.713220"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.645026"
                }
            ],
            "overall_sentiment_score": 0.108491,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PG",
                    "relevance_score": "0.993035",
                    "ticker_sentiment_score": "0.278578",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.647226",
                    "ticker_sentiment_score": "0.057540",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.642628",
                    "ticker_sentiment_score": "0.094262",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.555990",
                    "ticker_sentiment_score": "-0.064933",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Blackstone CEO Schwarzman Earns Over $1.2 Billion In 2025 Amid Record Profits",
            "url": "https://www.benzinga.com/markets/equities/26/02/50950972/blackstone-ceo-schwarzman-earns-over-1-2-billion-in-2025-amid-record-profits",
            "time_published": "20260228T050950",
            "authors": [
                "Mohd Haider"
            ],
            "summary": "Blackstone CEO Stephen Schwarzman earned over $1.2 billion in 2025, driven by the alternative asset manager's record profits. This figure, slightly below his 2022 record, includes $1.1 billion in dividends and $125.6 million from carried interest and incentive fees. President Jon Gray also saw significant earnings and forecasted 2026 as \"the year of the IPO.\"",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2026/02/28/Konskie--Poland---November-21--2024-Blac.jpeg?quality=85&auto=webp&width=850",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "Benzinga",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.906058"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.816780"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.716311"
                },
                {
                    "topic": "ipo",
                    "relevance_score": "0.644684"
                }
            ],
            "overall_sentiment_score": 0.344029,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BX",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.321493",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is It Too Late To Consider Cboe Global Markets (CBOE) After Its Strong Multi\u2011Year Rally?",
            "url": "https://simplywall.st/stocks/us/diversified-financials/bats-cboe/cboe-global-markets/news/is-it-too-late-to-consider-cboe-global-markets-cboe-after-it",
            "time_published": "20260228T050250",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Cboe Global Markets (CBOE) has seen a significant multi-year rally, but two valuation approaches suggest the stock may now be overvalued. Simply Wall St's Excess Returns model indicates CBOE is 13.8% overvalued, while its P/E ratio is considerably higher than its proprietary \"Fair Ratio,\" further suggesting overvaluation based on earnings. The article advises investors to explore different valuation narratives to align with their assumptions.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.912162"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.745356"
                }
            ],
            "overall_sentiment_score": -0.061316,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CBOE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.274987",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.627101",
                    "ticker_sentiment_score": "0.119029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CME",
                    "relevance_score": "0.637698",
                    "ticker_sentiment_score": "0.145358",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Keurig Dr Pepper (KDP) Gets Price Target Increase to $32 from Barclays",
            "url": "https://finviz.com/news/325918/keurig-dr-pepper-kdp-gets-price-target-increase-to-32-from-barclays",
            "time_published": "20260228T050028",
            "authors": [
                "Vardah Gill"
            ],
            "summary": "Barclays has increased its price target for Keurig Dr Pepper (KDP) to $32 from $30, maintaining an Equal Weight rating. CEO Timothy Cofer highlighted 2025 as a strong year with solid results, achievement of full-year guidance, and significant retail sales growth driven by innovation and strong execution. The company is also preparing for the acquisition of JDE Peet\u2019s and future separation into two focused businesses, with priorities for 2026 including double-digit EPS growth and integration of the acquisition.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/29083015/KDP-insidermonkey-1695990613284.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.917462"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.838190"
                },
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.719477"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.603455"
                }
            ],
            "overall_sentiment_score": 0.495088,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KDP",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.454239",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Chipotle opens in Harpersfield Township",
            "url": "https://www.starbeacon.com/news/chipotle-opens-in-harpersfield-township/article_703fc753-7984-4523-807a-b83c41cc1036.html",
            "time_published": "20260228T045954",
            "authors": [
                "WARREN DILLAWAY"
            ],
            "summary": "A new Chipotle Mexican Restaurant has opened in Harpersfield Township, drawing customers and long lines to its drive-thru shortly after its 10:45 a.m. opening. Located at 1800 South Broadway, the restaurant is leasing land from SPIRE Academy, whose Chief Executive Officer Steve Sanders expressed excitement about the new addition to the Route 45 corridor and anticipates more restaurants will open in the area. The restaurant offers a curated menu with high-protein options, including the Double High Protein Bowl and High Protein-High Fiber Bowl.",
            "banner_image": "https://bloximages.chicago2.vip.townnews.com/starbeacon.com/content/tncms/assets/v3/editorial/f/d2/fd2bfcd9-45be-44ec-ae55-b1e4c9730ed4/69a1dfbe98cb8.image.jpg?resize=400%2C212",
            "source": "Star Beacon",
            "category_within_source": "General",
            "source_domain": "Star Beacon",
            "topics": [
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.931293"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.628061"
                }
            ],
            "overall_sentiment_score": 0.420368,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CMG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.447190",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Realty Income Broadens Portfolio As Valuation Screens Undervalued For Investors",
            "url": "https://simplywall.st/stocks/us/real-estate/nyse-o/realty-income/news/realty-income-broadens-portfolio-as-valuation-screens-underv",
            "time_published": "20260228T045950",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Realty Income (NYSE:O) is diversifying its portfolio beyond retail properties, venturing into industrial assets in Mexico, casinos, and data centers through a new Core Plus Fund and a joint venture with GIC. While maintaining its strong dividend focus, these strategic moves aim to broaden income sources and reduce tenant concentration risk. The company's shares are currently trading below Simply Wall St's fair value estimate, despite being slightly above analyst targets.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "real_estate",
                    "relevance_score": "1.000000"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.923189"
                }
            ],
            "overall_sentiment_score": 0.213856,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "O",
                    "relevance_score": "0.996342",
                    "ticker_sentiment_score": "0.307774",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KIM",
                    "relevance_score": "0.600800",
                    "ticker_sentiment_score": "0.102410",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REG",
                    "relevance_score": "0.643227",
                    "ticker_sentiment_score": "0.105340",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ulta Beauty Weighs Global Growth Inclusivity And AI Against Premium Valuation",
            "url": "https://simplywall.st/stocks/us/retail/nasdaq-ulta/ulta-beauty/news/ulta-beauty-weighs-global-growth-inclusivity-and-ai-against",
            "time_published": "20260228T045920",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Ulta Beauty is pursuing a multifaceted growth strategy under its new CEO, Kecia Steelman, focusing on global expansion, inclusivity initiatives like the MUSE Accelerator program for women and BIPOC-owned brands, and AI-driven personalization. While the stock has seen significant returns over the past year and five years, it trades above its estimated fair value. Investors are advised to monitor revenue, earnings, MUSE program traction, and AI's impact on customer engagement, especially given the company's premium valuation and potential execution risks.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.932181"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.832888"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.708115"
                }
            ],
            "overall_sentiment_score": 0.15508,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ULTA",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.294097",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.644935",
                    "ticker_sentiment_score": "0.147483",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.646512",
                    "ticker_sentiment_score": "0.100216",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LOW",
                    "relevance_score": "0.644652",
                    "ticker_sentiment_score": "0.137243",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P Global Uses CERAWeek To Deepen Role In Energy Transition",
            "url": "https://simplywall.st/stocks/us/diversified-financials/nyse-spgi/sp-global/news/sp-global-uses-ceraweek-to-deepen-role-in-energy-transition",
            "time_published": "20260228T045610",
            "authors": [
                "Simply Wall St Reviewed by Bailey Pemberton"
            ],
            "summary": "S&P Global is hosting the 44th annual CERAWeek conference to reinforce its position as a central source for energy information and policy discussions. The event brings together key stakeholders to discuss energy transition, geopolitics, and new technologies, highlighting S&P Global's capabilities in data, analytics, and consulting. For investors, CERAWeek offers insights into long-term energy themes and helps solidify S&P Global's growth narrative around energy transition and climate products.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.931939"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.825266"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.731861"
                }
            ],
            "overall_sentiment_score": 0.046008,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.316313",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSCI",
                    "relevance_score": "0.722038",
                    "ticker_sentiment_score": "-0.112105",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.612251",
                    "ticker_sentiment_score": "-0.108415",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tivic Health partners with Scorpius for drug manufacturing",
            "url": "https://ng.investing.com/news/company-news/tivic-health-partners-with-scorpius-for-drug-manufacturing-93CH-1919956",
            "time_published": "20260228T045306",
            "authors": [
                "Investing.com"
            ],
            "summary": "Tivic Health Systems Inc. has finalized an agreement with Scorpius BioManufacturing for the GMP manufacturing validation of Entolimod\u2122, its primary drug candidate for Acute Radiation Syndrome. This partnership values the program at approximately $4.1 million and is a crucial step towards the drug's Biological Licensing Application to the FDA. Scorpius Holdings, meanwhile, faces challenges including a NYSE American delisting notification but anticipates significant sales growth this year, with a projected revenue increase of 156%.",
            "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
            "source": "Investing.com Nigeria",
            "category_within_source": "General",
            "source_domain": "Investing.com Nigeria",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.904008"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.831872"
                }
            ],
            "overall_sentiment_score": 0.224996,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SCPX",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.207529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Sanofi and Regeneron\u2019s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment",
            "url": "https://www.webwire.com/ViewPressRel.asp?aId=351237",
            "time_published": "20260228T045250",
            "authors": [],
            "summary": "Sanofi and Regeneron's Dupixent has received a positive opinion from the European Medicines Agency's CHMP for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged two to 11 years. If approved, Dupixent would be the first targeted therapy for this age group in the EU whose symptoms are inadequately controlled by standard antihistamine treatments. This recommendation is supported by data from the LIBERTY-CUPID clinical study program.",
            "banner_image": "https://photos.webwire.com/prmedia/8/351237/351237-1-m.jpg?20262281120",
            "source": "WebWire",
            "category_within_source": "General",
            "source_domain": "WebWire",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.942129"
                }
            ],
            "overall_sentiment_score": 0.405928,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNY",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.406969",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.967096",
                    "ticker_sentiment_score": "0.382990",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Royal Caribbean Kreuzfahrt: What US Travelers Should Know Now",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/royal-caribbean-kreuzfahrt-what-us-travelers-should-know-now/68619924",
            "time_published": "20260228T045101",
            "authors": [],
            "summary": "This article provides a comprehensive overview for US travelers considering a Royal Caribbean cruise, or \"Kreuzfahrt.\" It highlights the current trends of larger ships, advanced onboard technology, and short, impactful getaways, emphasizing that Royal Caribbean is aggressively targeting the US market with family-friendly experiences and resort-level amenities. The piece also discusses pricing, potential hidden costs, and the importance of early booking while noting both the strengths (entertainment, private islands) and weaknesses (crowds, upselling) of the Royal Caribbean experience.",
            "banner_image": "https://mdb.ad-hoc-news.de/media/bild-2471712_200_200.jpg",
            "source": "AD HOC NEWS",
            "category_within_source": "General",
            "source_domain": "AD HOC NEWS",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.936309"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.609295"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.730829"
                }
            ],
            "overall_sentiment_score": 0.422327,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "RCL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.439123",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "ConocoPhillips (COP) Stock Gains UBS Confidence as Willow Project Advances",
            "url": "https://finviz.com/news/325897/conocophillips-cop-stock-gains-ubs-confidence-as-willow-project-advances",
            "time_published": "20260228T044358",
            "authors": [
                "Sheryar Siddiq"
            ],
            "summary": "UBS has increased its price target for ConocoPhillips (NYSE:COP) to $130, maintaining a Buy rating, despite recent quarterly earnings missing expectations. The firm's confidence is partly due to the progress of COP's Willow project, which is expected to be halfway complete this construction season and could significantly expand resource development. UBS also sees ConocoPhillips as the best-positioned company to extract value from Venezuela, given its existing claims and potential production in the region.",
            "banner_image": "https://www.insidermonkey.com/blog/wp-content/uploads/2013/06/ConocoPhillips-COP.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.852959"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.911505"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.782000"
                }
            ],
            "overall_sentiment_score": 0.271911,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COP",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.420307",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.648227",
                    "ticker_sentiment_score": "0.121452",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "HANMI FINANCIAL CORP SEC 10-K Report",
            "url": "https://www.tradingview.com/news/tradingview:e783c2bd36424:0-hanmi-financial-corp-sec-10-k-report/",
            "time_published": "20260228T043309",
            "authors": [],
            "summary": "Hanmi Financial Corporation has released its 2024 Form 10-K report, providing a detailed overview of its financial performance, business operations, and strategic initiatives. The report indicates a decrease in net income and earnings per diluted share compared to the previous year, primarily due to reduced net interest income and increased noninterest expenses. Despite these challenges, the company actively manages interest rate risk, maintains a strong capital position exceeding regulatory requirements, and focuses on community engagement and diversity in its workforce.",
            "banner_image": null,
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.938280"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.807036"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.632767"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.622312"
                }
            ],
            "overall_sentiment_score": -0.285927,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "HAFC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.274045",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Barclays Cuts KKR & Co. (KKR) Price Target Amid Mixed Q4 Results, Maintains Overweight Rating",
            "url": "https://finviz.com/news/325899/barclays-cuts-kkr-co-kkr-price-target-amid-mixed-q4-results-maintains-overweight-rating",
            "time_published": "20260228T042238",
            "authors": [
                "Sheryar Siddiq"
            ],
            "summary": "Barclays has reduced its price target for KKR & Co. Inc. to $136 from $159 following mixed Q4 earnings, though it maintains an Overweight rating. While KKR's adjusted net income per share missed analyst forecasts, revenue significantly outperformed expectations. The company also raised $28 billion in funds and reaffirmed its EPS forecast for fiscal year 2026, largely dependent on increased realizations.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2024/06/11112443/yorgos-ntrahas-mcAUHlGirVs-unsplash-1.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.943814"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.815080"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.709141"
                }
            ],
            "overall_sentiment_score": -0.223473,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "KKR",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.202939",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Oracle's Ambitious Pivot Faces Scrutiny Over Mounting Debt",
            "url": "https://www.aktiencheck.de/news/Artikel-Oracle_s_Ambitious_Pivot_Faces_Scrutiny_Over_Mounting_Debt-19515791",
            "time_published": "20260228T042054",
            "authors": [],
            "summary": "Oracle Corporation is facing scrutiny from investors due to a decline in its share value and concerns over the cost of its aggressive pivot into AI and cloud computing. The company's mounting debt and ongoing legal challenges regarding corporate disclosures are casting a shadow over its growth prospects. Despite these challenges, some analysts remain optimistic about Oracle's long-term earnings growth from its cloud and AI investments, particularly after a recent capital raise to fund expansion.",
            "banner_image": "https://www-boerse-global-de.b-cdn.net/wp-content/uploads/ai-imgs/US68389X1054-2026-02-28-05-21-05.png",
            "source": "Aktiencheck",
            "category_within_source": "General",
            "source_domain": "Aktiencheck",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.925556"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.808961"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.727764"
                }
            ],
            "overall_sentiment_score": -0.211601,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "ORCL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.204117",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Insider Buying: Laura Clark Acquires Shares of Rexford Industrial Realty Inc (REXR)",
            "url": "https://www.gurufocus.com/news/8664381/insider-buying-laura-clark-acquires-shares-of-rexford-industrial-realty-inc-rexr",
            "time_published": "20260228T041438",
            "authors": [],
            "summary": "Laura Clark, Chief Operating Officer of Rexford Industrial Realty Inc (REXR), recently purchased 5,310 shares of the company, bringing her total ownership to 5,310 shares. This transaction is part of a balanced insider trading trend at the company. Despite the price-earnings ratio being higher than the industry median, the stock appears modestly undervalued based on its GF Value.",
            "banner_image": "https://static.gurufocus.com/cdn-cgi/image/width=600,quality=100/logos/0C0000A4T9.png?14",
            "source": "GuruFocus",
            "category_within_source": "General",
            "source_domain": "GuruFocus",
            "topics": [
                {
                    "topic": "real_estate",
                    "relevance_score": "0.937439"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.727006"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.630713"
                }
            ],
            "overall_sentiment_score": 0.003538,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "REXR-P-B",
                    "relevance_score": "0.341581",
                    "ticker_sentiment_score": "0.030512",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Merck & Co. Inc.: Why This Big Pharma Stock Is Suddenly Back on Watchlists",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/merck-and-co-inc-why-this-big-pharma-stock-is-suddenly-back-on/68619890",
            "time_published": "20260228T041348",
            "authors": [],
            "summary": "Merck & Co. Inc. is back on watchlists due to fresh data, pipeline headlines, and ongoing oncology momentum, particularly with its cancer drug Keytruda and vaccine business. The stock is attractive for those interested in healthcare, cancer drugs, and dividends, but also carries risk due to patent expirations later in the decade. Investors should assess Merck's strong existing cash flow and dividend against the high-stakes clinical trials and acquisitions aimed at securing its post-Keytruda future.",
            "banner_image": null,
            "source": "AD HOC NEWS",
            "category_within_source": "General",
            "source_domain": "AD HOC NEWS",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.925490"
                }
            ],
            "overall_sentiment_score": 0.077686,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.335243",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.584083",
                    "ticker_sentiment_score": "0.044917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.597773",
                    "ticker_sentiment_score": "0.011013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.555333",
                    "ticker_sentiment_score": "0.041923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.550705",
                    "ticker_sentiment_score": "0.025489",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Fair Isaac (FICO) director Manolis sells $638,367 in stock",
            "url": "https://www.investing.com/news/insider-trading-news/fair-isaac-fico-director-manolis-sells-638367-in-stock-93CH-4533205",
            "time_published": "20260228T040816",
            "authors": [
                "Investing.com"
            ],
            "summary": "Fair Isaac (FICO) director Manolis sold 520 shares of company stock for $638,367 on February 25, 2026, while also exercising options to acquire an equivalent number of shares. Following the sale, Manolis directly owns 344 shares. This transaction comes as FICO is considered overvalued according to InvestingPro analysis, despite the company recently reporting strong first-quarter 2026 earnings and announcing a new $1.5 billion stock repurchase program, prompting positive analyst ratings.",
            "banner_image": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
            "source": "Investing.com",
            "category_within_source": "General",
            "source_domain": "Investing.com",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.943273"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.834739"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.727339"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.647223"
                }
            ],
            "overall_sentiment_score": -0.232056,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "FICO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.208641",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Campbell Soup Stock After Earnings: Defensive Bargain Or Value Trap for U.S. Investors?",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/campbell-soup-stock-after-earnings-defensive-bargain-or-value-trap-for/68619851",
            "time_published": "20260228T035802",
            "authors": [],
            "summary": "Campbell Soup Co. (CPB) recently released its earnings, showing modest revenue growth driven by pricing and improved margins. The stock is considered a defensive pick for U.S. investors seeking stability and dividends in a volatile market, but it offers slow growth. Analysts maintain a \"Hold\" rating, emphasizing its role as an income and stability play rather than a high-growth opportunity.",
            "banner_image": null,
            "source": "AD HOC NEWS",
            "category_within_source": "General",
            "source_domain": "AD HOC NEWS",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.903351"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.816914"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.739149"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.604430"
                }
            ],
            "overall_sentiment_score": 0.05877,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CPB",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.095385",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is It Too Late To Consider Teledyne Technologies (TDY) After Strong Recent Share Gains?",
            "url": "https://simplywall.st/stocks/us/tech/nyse-tdy/teledyne-technologies/news/is-it-too-late-to-consider-teledyne-technologies-tdy-after-s",
            "time_published": "20260228T035611",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Teledyne Technologies (TDY) has seen significant share gains recently, prompting investors to question its current valuation. According to a Discounted Cash Flow analysis and a Price-to-Earnings comparison against a proprietary \"Fair Ratio,\" the stock appears overvalued. Investors are encouraged to explore community narratives and advanced valuation tools provided by Simply Wall St to form their own conclusions.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.815903"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.944883"
                }
            ],
            "overall_sentiment_score": -0.190423,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "TDY",
                    "relevance_score": "0.963786",
                    "ticker_sentiment_score": "-0.383138",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "KEYS",
                    "relevance_score": "0.577351",
                    "ticker_sentiment_score": "0.038302",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is J. M. Smucker (SJM) Pricing Reflect Its DCF Upside After Recent Share Price Rebound",
            "url": "https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-sjm/j-m-smucker/news/is-j-m-smucker-sjm-pricing-reflect-its-dcf-upside-after-rece",
            "time_published": "20260228T035609",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "This article analyzes J. M. Smucker (SJM) stock valuation, concluding it is undervalued by 56.4% based on a Discounted Cash Flow (DCF) model, with an estimated fair value of $265.72 per share against a current price of $115.95. However, it appears slightly overvalued when using the Price to Sales (P/S) ratio, trading at 1.39x compared to a fair ratio of 1.28x. The analysis also introduces \"Narratives\" as a tool for investors to customize valuation models based on their own assumptions.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.908300"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.827735"
                }
            ],
            "overall_sentiment_score": 0.024173,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SJM",
                    "relevance_score": "0.317080",
                    "ticker_sentiment_score": "0.033450",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Forlenza, Seacoast Banking EVP & CRO, sells $415,691 in SBCF stock",
            "url": "https://m.uk.investing.com/news/insider-trading-news/forlenza-seacoast-banking-evp--cro-sells-415691-in-sbcf-stock-93CH-4533061?ampMode=1",
            "time_published": "20260228T035300",
            "authors": [
                "Investing.com"
            ],
            "summary": "Joseph M. Forlenza, EVP and CRO of Seacoast Banking Corp of Florida (SBCF), sold 12,635 shares of common stock for $415,691 on February 26, 2026, while also exercising options to acquire an equal number of shares for $393,580. This transaction occurred amidst an 8% decline in the stock price over the past week. Despite the recent dip and a mixed Q4 2025 earnings report with an EPS miss but revenue beat, InvestingPro suggests the stock is undervalued, and the company has consistently raised dividends for five years.",
            "banner_image": "https://i-invdn-com.investing.com/msite/img/install_apps/mobile-icon-banner.svg",
            "source": "Investing.com UK",
            "category_within_source": "General",
            "source_domain": "Investing.com UK",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.918353"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.712132"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.647103"
                }
            ],
            "overall_sentiment_score": -0.203331,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "SBCF",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.228951",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Recursion\u2019s First Clinical Signal And Sanofi Milestone Test AI Drug Thesis",
            "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/recursions-first-clinical-signal-and-sanofi-milestone-test-a",
            "time_published": "20260228T035250",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Recursion Pharmaceuticals reported positive clinical proof-of-concept for REC-4881 and achieved a fifth collaboration milestone with Sanofi, indicating progress in its AI-driven drug discovery. The company has extended its cash runway into early 2028, providing funding visibility despite ongoing losses. Investors are evaluating whether these advancements can offset the continuous cash burn and reliance on external funding sources.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.912042"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.809751"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.703599"
                }
            ],
            "overall_sentiment_score": 0.232331,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNY",
                    "relevance_score": "0.806274",
                    "ticker_sentiment_score": "0.236557",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "NEOS Nasdaq-100 Hedged Equity Income ETF (QQQH) Dividend Yield 2026 & History",
            "url": "https://www.marketbeat.com/stocks/NASDAQ/QQQH/dividend/",
            "time_published": "20260228T035218",
            "authors": [],
            "summary": "This article provides a detailed analysis of the NEOS Nasdaq-100 Hedged Equity Income ETF (QQQH) dividend, including its current yield, annual dividend amount, payment frequency, and historical data. It highlights that QQQH pays a monthly dividend with a 9.02% yield and details upcoming and past payment dates, alongside comparisons with market averages. The article serves as a comprehensive resource for investors interested in QQQH's dividend performance.",
            "banner_image": "https://www.marketbeat.com/images/master/MarketBeat-logo-r-white.svg?v=2019",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.932787"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.817105"
                }
            ],
            "overall_sentiment_score": 0.328938,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "QQQH",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.338429",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "QDVO Stock Fund Price and Chart \u2014 AMEX:QDVO",
            "url": "https://www.tradingview.com/symbols/AMEX-QDVO/",
            "time_published": "20260228T035211",
            "authors": [],
            "summary": "The Amplify CWP Growth & Income ETF (QDVO) seeks risk-adjusted returns by investing in 20-40 large-cap US stocks with consistent earnings growth and strong cash flows, complemented by a tactical covered call option strategy. Launched on August 22, 2024, the actively managed fund aims for combined gross income from dividends, option premiums, and capital appreciation, while also maintaining liquidity. Key statistics include assets under management of $615.84M USD and a dividend yield of 10.24%.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/amplify--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.928824"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.728204"
                }
            ],
            "overall_sentiment_score": -0.387037,
            "overall_sentiment_label": "Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "QDVO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.415774",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "QQA Top Holdings List & Exposure (Invesco QQQ Income Advantage ETF)",
            "url": "https://www.marketbeat.com/stocks/NASDAQ/QQA/holdings/",
            "time_published": "20260228T035205",
            "authors": [],
            "summary": "This article details the top holdings and exposure of the Invesco QQQ Income Advantage ETF (QQA). It lists the top 25 stock holdings by weight, including Invesco Premier U.S. Government Money Portfolio, NVIDIA, and Apple, which collectively represent 72.48% of the fund. The report also breaks down QQA's geographic, currency, sector, and industry exposures, showing a significant concentration in the United States and the Technology sector, particularly Semiconductors.",
            "banner_image": null,
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.949702"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.746490"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.647061"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.623163"
                }
            ],
            "overall_sentiment_score": 0.115352,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "QQA",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.125055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.820286",
                    "ticker_sentiment_score": "0.149509",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.722441",
                    "ticker_sentiment_score": "0.119468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.637058",
                    "ticker_sentiment_score": "0.115874",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.604321",
                    "ticker_sentiment_score": "0.119710",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TD Cowen Raises SolarEdge (SEDG) Price Target Amid Strong Q4 2025 Performance",
            "url": "https://finviz.com/news/325906/td-cowen-raises-solaredge-sedg-price-target-amid-strong-q4-2025-performance",
            "time_published": "20260228T035138",
            "authors": [
                "Sheryar Siddiq"
            ],
            "summary": "TD Cowen has raised its price target for SolarEdge (SEDG) to $43 from $38, maintaining a Buy rating after the company's strong Q4 2025 performance. SolarEdge reported a continuous gross margin growth to 16.64% and positive free cash flow, with an adjusted loss of $0.14 per share, significantly better than projected. Revenue topped estimates at $335.4 million, marking its fourth consecutive quarter of revenue increase, driven by exports, Nexis, and a single SKU.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2016/02/11032657/shutterstock_251888335.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.919605"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.803641"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.742100"
                }
            ],
            "overall_sentiment_score": 0.430597,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SEDG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.425474",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "A Look At Bank Of Montreal\u2019s (TSX:BMO) Valuation After Record Earnings And Shareholder Payouts",
            "url": "https://simplywall.st/stocks/ca/banks/tsx-bmo/bank-of-montreal-shares/news/a-look-at-bank-of-montreals-tsxbmo-valuation-after-record-ea/amp",
            "time_published": "20260228T035138",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Bank of Montreal (TSX:BMO) recently reported strong quarterly earnings, exceeding analyst expectations, with record revenue and ongoing share buybacks contributing to a robust 12-month share price return of 37.44%. While one popular valuation model suggests the stock is currently at fair value or slightly overvalued, trading just above CA$195.80, a discounted cash flow (DCF) model indicates it may be undervalued by about 29% at CA$196.31 compared to an estimated value of CA$274.92. This presents a mixed picture for investors, prompting a closer look at the differing valuation perspectives.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.926848"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.703023"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.646306"
                }
            ],
            "overall_sentiment_score": 0.049402,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SHNY",
                    "relevance_score": "0.314827",
                    "ticker_sentiment_score": "0.043842",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J6322493 Bond Price and Chart \u2014 FINRA:J6322493",
            "url": "https://www.tradingview.com/symbols/FINRA-J6322493/",
            "time_published": "20260228T035027",
            "authors": [],
            "summary": "This page provides detailed information on the J6322493 bond issued by Jacobs Solutions Inc., including its bond price, chart, and key financial terms. The bond has a 5.375% coupon rate and matures on March 3, 2036. It also offers an overview of Jacobs Solutions Inc. and related bond analytics.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/jacobs-engineering--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.922925"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.724185"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.623032"
                }
            ],
            "overall_sentiment_score": 0.106893,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "J",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.103741",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Humana (HUM) Valuation Check After Prolonged Share Price Weakness And Regulatory Scrutiny",
            "url": "https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-valuation-check-after-prolonged-share-price-weakn-1",
            "time_published": "20260228T034125",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Humana (HUM) has experienced prolonged share price weakness, with its stock down over various periods despite being considered 10.5% undervalued with a fair value of $212.87. This valuation narrative, however, is heavily influenced by the intensifying regulatory scrutiny on the Medicare Advantage sector, which could impact Humana's margins and documentation practices. Investors are advised to examine the underlying data and potential risks before making investment decisions.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.923952"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.846117"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.732829"
                }
            ],
            "overall_sentiment_score": 0.071812,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HUM",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.110951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.633571",
                    "ticker_sentiment_score": "0.031770",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELV",
                    "relevance_score": "0.624657",
                    "ticker_sentiment_score": "0.031096",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Danaher\u2019s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation",
            "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danahers-us99b-masimo-deal-refocuses-growth-on-diagnostics-v",
            "time_published": "20260228T034106",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Danaher (NYSE:DHR) has agreed to acquire Masimo Corporation for $9.9 billion in a cash and stock deal, aiming to expand its presence in healthcare technology and diagnostic solutions. This acquisition positions Masimo as a standalone business within Danaher\u2019s Diagnostics segment. The deal signifies Danaher's strategic focus on diagnostics, coming at a time of mixed share performance for the company.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "1.000000"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.943622"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.841469"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.747340"
                }
            ],
            "overall_sentiment_score": 0.154466,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DHR",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.276612",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.645829",
                    "ticker_sentiment_score": "0.124993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "A",
                    "relevance_score": "0.604283",
                    "ticker_sentiment_score": "0.120132",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Phillips 66\u2019s Direct Venezuelan Crude Move And Higher Dividend Altering The Investment Case For PSX?",
            "url": "https://simplywall.st/stocks/us/energy/nyse-psx/phillips-66/news/is-phillips-66s-direct-venezuelan-crude-move-and-higher-divi",
            "time_published": "20260228T034100",
            "authors": [
                "Simply Wall St",
                "Sasha Jovanovic"
            ],
            "summary": "Phillips 66 is seeking U.S. approval to directly purchase heavy crude from Venezuela's PDVSA starting April 2026, aiming to improve feedstock economics. Simultaneously, the company increased its quarterly dividend to US$1.27 per share, signaling management's confidence in its cash flow. Investors should consider how these moves, alongside refining margin pressures and operational costs, will impact Phillips 66's financial future and its ability to sustain shareholder returns.",
            "banner_image": "https://images.simplywall.st/company/15e05696-3826-44c3-b624-607cef9cf46e/chart/quote-price",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.939395"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.809756"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.907272"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.601055"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.714196"
                }
            ],
            "overall_sentiment_score": 0.159097,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PSX",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.209365",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VLO",
                    "relevance_score": "0.630957",
                    "ticker_sentiment_score": "0.102537",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MPC",
                    "relevance_score": "0.633763",
                    "ticker_sentiment_score": "0.149300",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Scotiabank Keeps Sector Perform on PEG, Public Service Enterprise Group Feb 2026",
            "url": "https://meyka.com/blog/scotiabank-keeps-sector-perform-on-peg-public-service-enterprise-group-feb-2026-2802/",
            "time_published": "20260228T033456",
            "authors": [
                "Danny Kontos"
            ],
            "summary": "Scotiabank has maintained a \"Sector Perform\" rating for Public Service Enterprise Group (PEG) but increased its price target to $92, indicating a neutral stance with slightly more optimism on valuation. This rating suggests investors should expect returns similar to the utility sector, aligning with a consensus of neutral views from other analysts like Evercore ISI. Meyka AI rates PEG with a B+ grade, reflecting its relative strength compared to peers based on various financial metrics and analyst consensus.",
            "banner_image": null,
            "source": "Meyka",
            "category_within_source": "General",
            "source_domain": "Meyka",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.903715"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.721117"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.607797"
                }
            ],
            "overall_sentiment_score": 0.109272,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PEG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.124277",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "APA Target Raised by Roth Capital as Firm Maintains Neutral View",
            "url": "https://finviz.com/news/325884/apa-target-raised-by-roth-capital-as-firm-maintains-neutral-view",
            "time_published": "20260228T033345",
            "authors": [
                "Vardah Gill"
            ],
            "summary": "Roth Capital analyst Leo Mariani raised the price target for APA Corporation (NASDAQ: APA) to $27 from $23, maintaining a Neutral rating, following the company's Q4 2025 earnings report. CEO John Christmann highlighted a successful 2025 with strong operational performance, accelerated cost reductions exceeding targets, and robust oil production in the Permian Basin. The company also saw strong momentum in Egypt with production growth supported by a new gas pricing framework.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/04164032/APA-insidermonkey-1696452029289.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.933739"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.804720"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.706915"
                }
            ],
            "overall_sentiment_score": 0.30597,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "APA",
                    "relevance_score": "0.968333",
                    "ticker_sentiment_score": "0.327355",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "HP has created a printer that provides meaningful usability benefits and real value to the user experience",
            "url": "https://globaldesignnews.com/hp-has-created-a-printer-that-provides-meaningful-usability-benefits-and-real-value-to-the-user-experience/",
            "time_published": "20260228T032528",
            "authors": [],
            "summary": "HP's Smart Tank 7600 Series printers, recognized with a 2022 Good Design Award, introduce innovative features designed to enhance user experience and visibility. These include illuminated ink tanks integrated into the housing for better aesthetics and visibility, along with a disappearing 3-inch touch user interface and front-facing RGB LED lighting that communicates printer status. The series targets high-volume printing needs for individuals and small businesses, incorporating an eco-friendly design using over 25 percent recycled plastic.",
            "banner_image": null,
            "source": "Global Design News",
            "category_within_source": "General",
            "source_domain": "Global Design News",
            "topics": [
                {
                    "topic": "technology",
                    "relevance_score": "0.920589"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.749651"
                }
            ],
            "overall_sentiment_score": 0.031593,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.336769",
                    "ticker_sentiment_score": "0.040294",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Keurig Dr Pepper (KDP) Gets Price Target Increase to $32 from Barclays",
            "url": "https://finviz.com/news/325881/keurig-dr-pepper-kdp-gets-price-target-increase-to-32-from-barclays",
            "time_published": "20260228T032333",
            "authors": [
                "Vardah Gill"
            ],
            "summary": "Barclays has raised its price target for Keurig Dr Pepper (KDP) to $32 from $30, while reiterating an Equal Weight rating. CEO Timothy Cofer highlighted a strong 2025, solid results, and future priorities including low double-digit EPS growth for 2026, the integration of JDE Peet\u2019s acquisition, and the separation into two independent businesses. The company is noted for its strong retail sales growth in the US and market share gains.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/29083015/KDP-insidermonkey-1695990613284.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.941149"
                },
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.805273"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.723633"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.611648"
                }
            ],
            "overall_sentiment_score": 0.505403,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KDP",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.517494",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC",
            "url": "https://www.streetinsider.com/PRNewswire/uniQure+N.V.+Securities+Fraud+Class+Action+Result+of+FDA+Approval+Delay+and+49%25+Stock+Decline+-+Investors+may+Contact+Lewis+Kahn%2C+Esq%2C+at+Kahn+Swick+%26amp%3B+Foti%2C+LLC/26084503.html",
            "time_published": "20260228T032244",
            "authors": [],
            "summary": "Kahn Swick & Foti, LLC (KSF) has announced a securities class action lawsuit against uniQure N.V. (NasdaqGS: QURE) due to a 49% stock decline following an FDA approval delay for its drug candidate, AMT-130. Investors who purchased shares between September 24, 2025, and October 31, 2025, and suffered substantial losses are encouraged to contact KSF by April 13, 2026, to file lead plaintiff applications. The lawsuit alleges that uniQure failed to disclose that the FDA did not agree with their data for a Biologics License Application (BLA) submission, making the BLA timing unclear.",
            "banner_image": "https://mma.prnewswire.com/media/2273998/2025_PR_SEC.jpg",
            "source": "StreetInsider",
            "category_within_source": "General",
            "source_domain": "StreetInsider",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.906360"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.820003"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.738142"
                }
            ],
            "overall_sentiment_score": -0.639816,
            "overall_sentiment_label": "Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "QURE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.621424",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "Eat Your Favourite Snack from an NBA Star\u2019s Hand with Latest Saatchi & Saatchi Campaign",
            "url": "https://lbbonline.com/news/eat-your-favourite-snack-from-an-nba-stars-hand-with-latest-saatchi-saatchi-campaign",
            "time_published": "20260228T031341",
            "authors": [],
            "summary": "Saatchi & Saatchi has launched a new campaign called 'Goldfish x Boban Hand Dish,' featuring an exact replica of NBA star Boban Marjanovi\u0107's 10.75-inch hand as a dish for Goldfish crackers. This campaign follows an earlier one where fans guessed how many Goldfish Boban could hold. Consumers will be able to claim this unique piece of sports memorabilia on March 1st at 3:01 PM ET.",
            "banner_image": "https://lbbonline.com/sencka\u0111.png",
            "source": "Little Black Book | LBBOnline",
            "category_within_source": "General",
            "source_domain": "Little Black Book | LBBOnline",
            "topics": [
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.818602"
                }
            ],
            "overall_sentiment_score": 0.435066,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CPB",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.448175",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline",
            "url": "https://www.streetinsider.com/PRNewswire/Ultragenyx+Pharmaceutical+Inc.+Notice+of+April+6%2C+2026+Application+Deadline+for+Class+Action+Lawsuit+-+Contact+Lewis+Kahn%2C+Esq.+at+Kahn+Swick+%26amp%3B+Foti%2C+LLC%2C+Before+Application+Deadline/26084490.html",
            "time_published": "20260228T030851",
            "authors": [],
            "summary": "Kahn Swick & Foti, LLC (KSF) has announced a class action securities lawsuit against Ultragenyx Pharmaceutical Inc. (RARE) following a significant 42% stock drop. The lawsuit alleges securities fraud between August 3, 2023, and December 26, 2025, after the company's Phase 3 studies for setrusumab failed to meet their primary endpoints, leading to plans for significant expense reductions. Investors who suffered losses have until April 6, 2026, to request to be appointed as lead plaintiff.",
            "banner_image": "https://mma.prnewswire.com/media/2273998/2025_PR_SEC.jpg",
            "source": "StreetInsider",
            "category_within_source": "General",
            "source_domain": "StreetInsider",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.901855"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.749352"
                }
            ],
            "overall_sentiment_score": -0.443532,
            "overall_sentiment_label": "Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "RARE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.427226",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "CSX Corp. News Updates",
            "url": "https://www.ttnews.com/categories/csx-corp?page=14",
            "time_published": "20260228T030301",
            "authors": [],
            "summary": "This article provides news updates regarding CSX Corp., a railroad business logistics company. It highlights that CSX's first-quarter net income and earnings-per-share increased by 22% year-over-year, attributed to higher shipping volumes. The content is part of a larger compilation of historical news on the company.",
            "banner_image": "https://www.ttnews.com/sites/default/files/styles/image_660_367_copy/public/images/articles/csx06_7.jpg",
            "source": "Transport Topics",
            "category_within_source": "General",
            "source_domain": "Transport Topics",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.913207"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.820508"
                }
            ],
            "overall_sentiment_score": 0.549603,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CSX",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.531187",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Insider Sell: Eva Manolis Sells Shares of Fair Isaac Corp (FICO)",
            "url": "https://www.gurufocus.com/news/8664349/insider-sell-eva-manolis-sells-shares-of-fair-isaac-corp-fico",
            "time_published": "20260228T025616",
            "authors": [
                "GuruFocus News"
            ],
            "summary": "Eva Manolis, a Director at Fair Isaac Corp (FICO), sold 520 shares of the company on February 25, 2026, reducing her holdings to 344 shares. This transaction is part of a pattern of 23 insider sells and no insider buys at FICO over the past year. The stock is currently trading at $1,227.63, and based on its GF Value, is considered modestly undervalued.",
            "banner_image": "https://static.gurufocus.com/cdn-cgi/image/width=600,quality=100/logos/0C000007K7.png?14",
            "source": "GuruFocus",
            "category_within_source": "General",
            "source_domain": "GuruFocus",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.937945"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.847413"
                }
            ],
            "overall_sentiment_score": -0.215331,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "FICO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.209621",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        }
    ]
}
